Bonesupport Holding AB (publ) – LSE:0RQO.L

Founder-led company

Bonesupport Holding AB (publ) stock price today

SEK 43.75
-351.8
-88.94%
Financial Health
0
1
2
3
4
5
6
7
8
9

Bonesupport Holding AB (publ) stock price monthly change

+39.77%
month

Bonesupport Holding AB (publ) stock price quarterly change

+39.77%
quarter

Bonesupport Holding AB (publ) stock price yearly change

+113.23%
year

Bonesupport Holding AB (publ) key metrics

Market Cap
 25.60B
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 4.44
Revenue
 735.16M
EBITDA
 90.07M
Income
 288.77M
Revenue Q/Q
 56.56%
Revenue Y/Y
 64.10%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 12.25%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Bonesupport Holding AB (publ) stock price history

Bonesupport Holding AB (publ) stock forecast

Bonesupport Holding AB (publ) financial statements

Profit Margin

Bonesupport Holding AB (publ) (LSE:0RQO.L): Profit margin
Sep 2023 158.20M 228.77M 144.61%
Dec 2023 172.74M 10.73M 6.21%
Mar 2024 184.41M 21.84M 11.85%
Jun 2024 219.79M 27.42M 12.48%
0RQO.L income statement history

Bonesupport Holding AB (publ) Financials Estimate

Bonesupport Holding AB (publ) (LSE:0RQO.L): Analyst Estimates
2027 2.22B 0

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Debt to Assets

Bonesupport Holding AB (publ) (LSE:0RQO.L): Debt to assets
Sep 2023 630956000 101.30M 16.06%
Dec 2023 688816000 143.63M 20.85%
Mar 2024 729173000 154.78M 21.23%
Jun 2024 752619000 123.21M 16.37%
0RQO.L balance sheet history

Cash Flow

Bonesupport Holding AB (publ) (LSE:0RQO.L): Cash Flow
Sep 2023 16.36M -572K -1.99M
Dec 2023 12.81M -4.02M -1.35M
Mar 2024 16.95M -1.92M -1.59M
Jun 2024 -66.74M -1.79M -1.69M
0RQO.L cash flow history

Bonesupport Holding AB (publ) alternative data

Bonesupport Holding AB (publ)
Employees

Bonesupport Holding AB (publ) (LSE:0RQO.L): Employee count
Aug 2023 104
Sep 2023 104
Oct 2023 104
Nov 2023 106
Dec 2023 105
Jan 2024 105
Feb 2024 105
Apr 2024 110
May 2024 118
Jun 2024 121
Jul 2024 121

Bonesupport Holding AB (publ) other data

Bonesupport Holding AB (publ)
Executives

Insider Compensation
Mr. Emil Billbäck (1970) Chief Executive Officer
 $7,270,000
Prof. Lars A. Lidgren (1943) Founder & Director
 $175,000
Mr. Håkan Johansson Chief Financial Officer
Mr. Johan Olsson Chief Operating Officer and Executive Vice President of Manufacturing & Supply
Ms. Annelie Aava Vikner Executive Vice President Global Marketing & Communications
Ms. Helena L. Brandt Head of HR
Dr. Michael Diefenbeck Executive Vice President of R&D, Medical & Clinical Affairs and Chief Medical Officer
Dr. Jerry Chang Executive Vice President of R&D, Regulatory and Clinical
Mr. Fergus MacLeod GM & Executive Vice President Commercial Operations EUROW
Ms. Kristina Ingvar Executive Vice President of Quality Management & Regulatory Affairs

Frequently Asked Questions (FAQ)

  • What's the price of Bonesupport Holding AB (publ) stock today?

    One share of Bonesupport Holding AB (publ) stock can currently be purchased for approximately $43.75.

  • When is Bonesupport Holding AB (publ)'s next earnings date?

    Unfortunately, Bonesupport Holding AB (publ)'s (0RQO.L) next earnings date is currently unknown.

  • Does Bonesupport Holding AB (publ) pay dividends?

    No, Bonesupport Holding AB (publ) does not pay dividends.

  • How much money does Bonesupport Holding AB (publ) make?

    Bonesupport Holding AB (publ) has a market capitalization of 25.60B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 79.76% to 591.08M US dollars.

  • What is Bonesupport Holding AB (publ)'s stock symbol?

    Bonesupport Holding AB (publ) is traded on the LSE under the ticker symbol "0RQO.L".

  • What is Bonesupport Holding AB (publ)'s primary industry?

    Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.

  • How do i buy shares of Bonesupport Holding AB (publ)?

    Shares of Bonesupport Holding AB (publ) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Bonesupport Holding AB (publ)'s key executives?

    Bonesupport Holding AB (publ)'s management team includes the following people:

    • Mr. Emil Billbäck Chief Executive Officer(age: 55, pay: $7,270,000)
    • Prof. Lars A. Lidgren Founder & Director(age: 82, pay: $175,000)
    • Mr. Håkan Johansson Chief Financial Officer
    • Mr. Johan Olsson Chief Operating Officer and Executive Vice President of Manufacturing & Supply
    • Ms. Annelie Aava Vikner Executive Vice President Global Marketing & Communications
    • Ms. Helena L. Brandt Head of HR
    • Dr. Michael Diefenbeck Executive Vice President of R&D, Medical & Clinical Affairs and Chief Medical Officer
    • Dr. Jerry Chang Executive Vice President of R&D, Regulatory and Clinical
    • Mr. Fergus MacLeod GM & Executive Vice President Commercial Operations EUROW
    • Ms. Kristina Ingvar Executive Vice President of Quality Management & Regulatory Affairs

  • Is Bonesupport Holding AB (publ) founder-led company?

    Yes, Bonesupport Holding AB (publ) is a company led by its founder Prof. Lars A. Lidgren.

  • How many employees does Bonesupport Holding AB (publ) have?

    As Jul 2024, Bonesupport Holding AB (publ) employs 121 workers, which is 10% more then previous quarter.

  • When Bonesupport Holding AB (publ) went public?

    Bonesupport Holding AB (publ) is publicly traded company for more then 7 years since IPO on 14 Dec 2017.

  • What is Bonesupport Holding AB (publ)'s official website?

    The official website for Bonesupport Holding AB (publ) is bonesupport.com.

  • How can i contact Bonesupport Holding AB (publ)?

    Bonesupport Holding AB (publ) can be reached via phone at +46 46 286 53 70.

Bonesupport Holding AB (publ) company profile:

Bonesupport Holding AB (publ)

bonesupport.com
Exchange:

LSE

Full time employees:

131

Industry:

Medical - Pharmaceuticals

Sector:

Healthcare

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.

+46 46 286 53 70
Scheelevägen 19
Lund, 223 70

:
ISIN: SE0009858152
CUSIP: W2R933137